BackPear Therapeutics Overview

Pear Therapeutics Net Tangible Assets

Track Pear Therapeutics's net tangible assets ($31M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$30.59M
66.18% YoYΔ $-59.85M vs prior year quarter

Peer trimmed avg / median

Loading

Pear Therapeutics Net Tangible Assets History

Loading

Pear Therapeutics vs. peers: Net Tangible Assets Comparison

Loading

Pear Therapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pear Therapeutics (PEAR) FAQ

The latest net tangible assets for PEAR is $31M as of December 2022. That compares with $90M in the prior-year period — down 66.2% year over year. Investors often review this figure alongside Pear Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, PEAR's net tangible assets moved from $90M to $31M — a 66.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pear Therapeutics's operating scale or balance-sheet position.

A net tangible assets figure of $31M for PEAR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PEAR's net tangible assets ($31M), review year-over-year change from $90M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.